
Morepen Laboratories Limited has informed the Exchange regarding a press release dated July 06, 2021, titled "RDIF and Morepen Laboratories announce production of the test batch of Sputnik V in India".
Filed with NSE · · 4 pages · English
Morepen Laboratories Limited has issued a press release regarding the production of a test batch of the Sputnik V vaccine in India, in collaboration with the Russian Direct Investment Fund. The announcement highlights the establishment of an exclusive production facility in Himachal Pradesh and the shipment of the first batch for quality control. This partnership is seen as a significant step towards expanding vaccine production capabilities in India and enhancing the availability of Sputnik V globally. The press release emphasizes the efficacy and safety of the Sputnik V vaccine, which has been registered in numerous countries worldwide.
Written by 6ix AI from the company’s filing. How 6ix writes summaries

Morepen Laboratories Limited has informed the Exchange regarding a press release dated July 06, 2021, titled "RDIF and Morepen Laboratories announce production of the test batch of Sputnik V in India".
Morepen Laboratories Limited on 6ix
Follow Morepen Laboratories into a list and get an email when it puts out news.
Follow Morepen Laboratories